Primary endocrine therapy in locally advanced breast cancers - The Nottingham experience

Breast Cancer Research and Treatment

Volumn 113, Issue 2, 2009, Pages 403-407

  Mathew, J ^a   Agrawal, A ^a   Asgeirsson, K S ^a   Buhari, S A ^a   Jackson, L R ^a   Cheung, K L ^a   Robertson, J F R ^a,b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

Breast cancer specific survival; Clinical benefit; Locally advanced primary breast cancer; Objective response; Primary endocrine therapy

Indexed keywords

ANASTROZOLE; ESTROGEN RECEPTOR; GOSERELIN; TAMOXIFEN;

ADULT; AGED; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; BREAST CANCER; CANCER HORMONE THERAPY; CANCER REGRESSION; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LIVER METASTASIS; LUNG METASTASIS; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CARCINOMA; COMBINED MODALITY THERAPY; ENGLAND; ESTROGEN RECEPTOR MODULATORS; ESTROGENS; FEMALE; GOSERELIN; HUMANS; MIDDLE AGED; NEOPLASMS, HORMONE-DEPENDENT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECEPTORS, ESTROGEN; RETROSPECTIVE STUDIES; SURVIVAL RATE; TAMOXIFEN; TREATMENT OUTCOME;

EID: 58149234215     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-008-9930-7     Document Type: Article

References (29)

1. PF Lebowitz Jennifer Eng-Wong SM Swain 2004 A phase 11 trial of neoadjuvant docetaxel and capecitabine for locally advanced breast cancer Clin Cancer Res 10 6764 6769
2. H Charfare S Limongelli AD Purushotham 2005 Neoadjuvant chemotherapy in breast cancer Br J Surg 92 14 23
3. M Colleoni S Gelber AS Coates 2001 Influence of endocrine-related factors on response to perioperative chemotherapy for patients with node negative breast cancer J Clinin Oncol 19 4141 4149
4. Gianni L, Baselga J, Eiermann W et al (2002) First report of European cooperative tral in operable breast cancer (ECTO): effects of primary systemic therapy on loco-regional disease (abstract). Proc Am Soc Clin Oncol 21: Abstract 132
5. SE Singletary R Shallenberger VF Guinee 1993 Breast cancer in the elderly Ann Surg 218 5 667 671
6. E Busch M Kemeny A Fremgen 1996 Patterns of breast cancer care in the elderly Cancer 78 1 101 111
7. KS McCarty Jr JS Silva EB Cox 1983 Relationship of age and menopausal status to estrogen receptor content in primary carcinoma of the breast Ann Surg 197 123 127
8. Early Breast Cancer Trialists Collaborative Group (2000) Analysis overview results. Fifth meeting of early breast cancer trialists collaborative group. Oxford, UK, pp 21-23
9. JF Robertson IO Ellis CW Elston RW Blamey 1992 Mastectomy or tamoxifen as initial therapy for operable breast cancerin elderly patients: 5 year follow-up Eur J cancer 28A 908 910
10. JC Gazet HT Ford RC Coombes 1994 Prospective randomised trial of tamoxifen vs surgery in elderly patients with breast cancer Eur J Surg Oncol 20 207 14
11. T Bates DL Riley J Houghton 1991 Breast cancer in elderly women: a cancer research campaign trial comparing treatment with tamoxifen and optimal surgery with tamoxifen alone. The early breast cancer working party BHr J Surg 78 591 4
12. G Mustacchi S Milani A Pluchinotta 1994 Tamoxifen or surgery plus tamoxifen as primary treatment for elderly patients with operable breast cancer: The G.R.E.T.A. trial. Group for research on endocrine therapy in the elderly Anticancer Res 14 2197 200
13. SM Tan KL Cheung PC Willsher RW Blamey SY Chan JFR Robertson 2001 Locally advanced primary breast cancer: medium-term results of a randomised trial of multimodal therapy versus initial hormone therapy EJC 37 2331 2338
14. L Harper-Wyne Catherine NPM Sacks K Shenton 2002 Comparison of the systemic and intramural effects of tamoxifen and aromatase inhibitor vorozole in postmenopausal patients with primary breast cancer J Clin Oncol 20 1026 1035
15. J Hayward 1977 Assessment of response to therapy in advanced breast cancer Cancer 39 1289 1293
16. E Thomas FA Homes TL Smith AU Budzar DK Fyre G Frachini 2004 The use of alternative, non-cross resistant adjuvant chemotherapy on the basis of pathologic response to a neoadjuvant doxorubicin-based regimen in women with operable breast cancer: Long-term results from a prospective randomised trial J of Clin Oncol 22 2294 2302
17. W Gradisher B Wedam M Jahanzeb 2005 Neoadjuvant docetaxel followed by adjuvant doxorubicin and cyclophosphamide in patients with stage III breast cancer Ann Oncol 16 1297 1304
18. J Shen V Valero TA Buchholz SE Singletray FC Ames M Ross 2004 Effective local control and long-term survival in patients with T4 locally advanced breast cancer treated with breast conservation therapy Ann Surg Oncol 11 854 860
19. K Erol E Baltali K Altundag 2005 Neoadjuvantt chemotherapy with cyclophosphamide, mithotrixate and 5-Flurouracil in locally advanced breast cancer Onkologie 28 81 85
20. A Favret R Carlson D Goffinet 2001 Locally advanced breast cancer: Is surgery necessory? Breast J 7 131 137
21. G Bonadonna P Valagussa C Brambilla 1998 Primary chemotherapy in operable breast cancer: Eight year experience at the Milan cancer institute J Clin Oncol 16 93 100
22. B Fisher J Bryant N Wolmark 1998 Effect of preoperative chemotherapy on the outcome of women with operable breast cancer J Clin Oncol 16 2672 2685
23. A Howell J Mackintosh M Jones 1998 The definition of 'no change' category in patients treated with endocrine therapy and chemotherapy for advanced carcinoma of the breast Eur J Cancer Clin Oncol 24 1267 1272
24. J Robertson PC Willsher KL Cheung 1997 The clinical relevance of static disease (no change) category for 6 months on endocrine therapy in patients with breast cancer Eur J Cancer Oncol 33 1774 1779
25. J Robertson A Howell A Buzdar 1999 Static disease on anastrozole provides similar benefit as objective response in patients with advanced breast cancer Breast Cancer Res Treat 58 157 162
26. H Mouridsen Y Sun M Gershanovich R Perez-Carrion 2004 Superiority of Letrozole to Tamoxifen in the first-line treatment of advanced breast cancer: evidence from metastatic subgroups and a test of functional ability Oncologist 9 5 489 496
27. B Thurlimann D Hess D Koberle 2004 Anastrozole (Arimidex) versus Tamoxifen as first-line therapy in post-menopausal women with advanced breast cancer: results of double blind cross-over SAKK trial 21/95- a sub-study of the TARGET(Tamoxifen or Arimidex Randomised group efficacy and tolerability) trial Breast Cancer Res Treat 85 3 247 254
28. J Mathew KS Asgeirsson A Agrawal 2007 Neoadjuvant chemotherapy in locally advanced primary breast cancers: the Nottingham experience Eur J Surg Oncol 33 8 972 976
29. MR Williams D Gilson L Marsh 1998 The early results from a randomised study of radiotherapy versus Nolvadex (Tamoxifen) as initial treatment for stage 111 breast cancer EJSO 14 3 235 240